Related Experiment Videos
Solution structure and dynamics of cyclic and acyclic cholinergic agonists
1Department of Pharmacology, College of Veterinary Medicine, Cornell University, Ithaca, New York 14853.
Biophysical Journal
|February 1, 1993
Summary
Cyclic nicotinic cholinergic agonists are more potent due to distinct stable conformers identified by NMR spectroscopy. These structural differences, particularly amide bond orientation, influence biological activity.
Area of Science:
- Medicinal Chemistry
- Biophysical Chemistry
- Structural Biology
Background:
- Nicotinic cholinergic agonists are crucial drug targets.
- Understanding structure-activity relationships is key to drug design.
- Previous studies indicated cyclic analogs are more potent than acyclic ones.
Purpose of the Study:
- To investigate the structural and dynamic properties of novel nicotinic cholinergic agonists.
- To elucidate the molecular basis for the increased potency of cyclic agonists.
- To characterize the conformational preferences and energetics of amide bond isomerization.
Main Methods:
- Synthesis of cyclic and acyclic nicotinic cholinergic agonists.
- Nuclear Magnetic Resonance (NMR) spectroscopy (1D and 2D) for structural analysis.
- Variable temperature NMR to study amide bond isomerization energetics.
Main Results:
- Identified two distinct stable conformers differing in amide bond orientation for both cyclic and acyclic compounds.
- Cyclic compounds exhibited equal energy conformers, while acyclic compounds (N,N,N,N'-tetramethyl-N'-acetylethylene-diamine iodide - TED) showed energetically unequal conformations.
- The more populated TED conformer is stabilized by electrostatic attraction between the carbonyl oxygen and quaternary amine nitrogen.
Conclusions:
- Conformational differences and amide bond isomerization kinetics of TED derivatives may hold biological significance.
- The study provides insights into how molecular flexibility and electrostatic interactions affect agonist potency.
- Structural characterization via NMR advances the understanding of nicotinic receptor ligand interactions.